RECENT WEBINARS
How To Activate AI Under GxP, Governance, And Security Constraints
AI insights are abundant in pharma, but action requires trust. Learn how governed, validated Industrial AI can move beyond advisory analytics to support compliant, auditable decisions.
Early Developability Assessment For Antibody Based Therapeutics
Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.
Comprehensive Bioprocess Control: Substrate, Metabolite And Product Analysis
Explore how multi-parameter bioprocess analyzers support monitoring of 30+ bioprocess parameters across mammalian and microbial systems to optimize yield and product quality.
A Novel Cell Selective Lentiviral Platform For CAR-T Engineering
Targeted lentiviral vectors enable rapid CAR‑T cell generation without extensive ex vivo manipulation. See how this approach demonstrates efficient in vitro and in vivo performance.
3 Critical UF/DF Challenges And How To Solve Them
High‑concentration mAbs change how UF/DF behaves. Learn how modern TFF platforms help address these challenges and maintain control as formulations move beyond traditional limits.
How Connected Digital Execution Turns Pharma Data Into Decisions
Disconnected systems slow investigations and delay batch release. Learn how a digitally connected execution ecosystem provides real-time context for alerts, enabling proactive control and faster decisions.
Engineering Precision In Genetic Medicines
Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.
From DNA To IND In As Little As 6 Months
Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.
Biologics Tech Transfer & Validation at Scale: A Better Path to GMP
Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.
Advancing In-Line PAT Solutions For Real-Time Batch Analysis
Shift from reactive sampling to continuous, data-driven control. Learn how in-line metabolic monitoring improves yield and batch consistency through real-time glucose and lactate insights.
Unlocking The Next Wave Of Cancer Vaccines
Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.
Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes
See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.
EU And PIC/S Annex 1: CCS Shortfalls After 2 Years Of Implementation
Explore how to elevate Contamination Control Strategies from static documents to inspection-ready, lifecycle tools, as well as practical approaches to Annex 1 compliance and risk-based CCS development.
OneTeam™: Setting A New Standard for Biotech Program Visibility
An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.
Less Risk, More Speed -The New Blueprint For Bioconjugate Development
A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.
Industrializing Cell Therapy With Perfusion
Explore how intensified perfusion strategies enable rapid, high‑density CAR‑T expansion, predictive scale‑down modeling, and efficient automated harvest, supporting shorter timelines and higher yields.
Defined Media, Defined Results: Scaling E. coli From Bench To Fermenter
Understand the benefits of chemically defined media in E. coli systems, explore real-world plasmid DNA data, and learn practical strategies for scaling to robust manufacturing.
Digital Design Meets Proven Performance: The Future Of Single-Use Assemblies
Single-use assembly design is evolving fast. Learn how scalable platforms, digital automation tools, and global supply networks are converging to support sustainable biopharma manufacturing at scale.
Applying AI And Rapid Prototyping To Media And Process Development
Hear from industry experts on how teams can integrate manufacturability considerations earlier through rapid prototyping, data-driven media development, and predictive modeling.
Strategies To Modernize Asset Performance In Manufacturing
Learn how to advance from reactive maintenance to predictive, data-driven operations, as well as about APM maturity stages, common transformation challenges, and practical steps to improve reliability.
Flexible Therapeutic Development: Balancing Speed, Cost, and Process
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.
Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development
Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.
Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems
Maintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.
How AI-Enabled Validation Technologies Enable The Predictive Plant
Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.
Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems
Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.
Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right
This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.
Integrated Thinking for Complex FIH Programs
See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.
Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up
Learn how small UF/DF decisions can create major scale-up challenges, as well as practical ways to improve membrane selection, reduce manual operations, and boost PD–MSAT alignment.
Bridging Discovery And CMC With Rapid Pools
Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.
Selecting A Prefillable Syringe System With Confidence
Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.